Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAZOOKA_221 rabies pre-exposure prophylaxis boostability trial
2025-524765-24-00Phase 3Authorised
- Sponsor
- Institute of Tropical Medicine Antwerp
- Start
- May 2026
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of Rabies vaccine in rabies (3 arms), sponsored by Institute of Tropical Medicine Antwerp. Primary endpoint: Adequate immune response at Day 7. Planned start May 2026; status: authorised.
02
Drugs
Rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on 2025-524765-24-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524765-24-00.